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In Brief
TMCO1 is an ER membrane channel that
detects overfilling of calcium stores and
restores calcium homeostasis, a function
that is disrupted in human CFT dysplasia.
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                                            SUMMARY
Maintaining homeostasis of Ca2+ stores in the
endoplasmic reticulum (ER) is crucial for proper
Ca2+ signaling and key cellular functions. The Ca2+-
release-activated Ca2+ (CRAC) channel is respon-
sible for Ca2+ influx and refilling after store depletion,
but how cells cope with excess Ca2+ when ER stores
are overloaded is unclear.We show that TMCO1 is an
ER transmembrane protein that actively prevents
Ca2+ stores from overfilling, acting as what we term
a ‘‘Ca2+ load-activated Ca2+ channel’’ or ‘‘CLAC’’
channel. TMCO1 undergoes reversible homotetra-
merization in response to ER Ca2+ overloading
and disassembly upon Ca2+ depletion and forms a
Ca2+-selective ion channel on giant liposomes.
TMCO1 knockout mice reproduce the main clinical
features of human cerebrofaciothoracic (CFT)
dysplasia spectrum, a developmental disorder linked
to TMCO1 dysfunction, and exhibit severe mishan-
dling of ER Ca2+ in cells. Our findings indicate that
TMCO1 provides a protective mechanism to prevent
overfilling of ER stores with Ca2+ ions.
INTRODUCTION
Calcium ion (Ca2+) is a highly versatile intracellular signal that
controls many different cellular functions such as contraction,
secretion, memory formation, gene transcription, cell growth,
and cell death (Berridge, 1993; Clapham, 2007). The endo-
plasmic reticulum (ER) is the main intracellular Ca2+ store. Ca2+
concentration in the ER ([Ca2+]ER) must bemaintained in a steady
state for proper Ca2+ signaling (Berridge et al., 2003; Clapham,
2007), and disarrangement of ER Ca2+ homeostasis has been
implicated in many severe diseases (Bezprozvanny and Matt-                                                 son, 2008; Sammels et al., 2010; Tu et al., 2006). Stimulation of
cells with a variety of physiological stimuli leads to an inositol-
1,4,5-trisphosphate (IP3)-mediated Ca
2+ release from ER and a
depletion of Ca2+ stores (Berridge et al., 2003). Cells evolve a
mechanism termed store-operated Ca2+ entry (SOCE) or capaci-
tative Ca2+ entry (CCE) to refill the cell and ER Ca2+ stores
(Cahalan, 2009; Lewis, 2007; Putney, 2009). It is known that
Ca2+-release-activated Ca2+ (CRAC) channels are responsible
for the SOCE activity and Ca2+ store refilling after store depletion
(Brandman et al., 2007; Feske et al., 2006; Liou et al., 2005; Luik
et al., 2008; Park et al., 2009; Prakriya et al., 2006; Roos et al.,
2005; Vig et al., 2006; Zhang et al., 2005). However, it remains
unclear if there is a mechanism for ER to extrude the excess
Ca2+ when the store gets overloaded.
Transmembrane and coiled-coil domains 1 (TMCO1)-defect
syndrome is characterized by distinctive craniofacial dysmor-
phism, skeletal anomalies, mental retardation, ataxia, and
many other clinical symptoms. A frameshift mutation in the
TMCO1 gene has been identified as the pathogenic cause for
this autosomal-recessive syndrome in the isolated Old Order
Amish of northeastern Ohio (Xin et al., 2010). The TMCO1
gene encodes a protein predicted to be 188 amino acids, and
its c.139_140delAG mutation is predicted to result in severe
protein truncation (p.Ser47X) leading to a loss of protein func-
tion. Non-Amish cases with a nonsense mutation in the
TMCO1 gene (that results in a p.Arg87X truncation) have
recently been reported (Alanay et al., 2014; Caglayan et al.,
2013). TMCO1-defect syndrome, initially thought to represent
a distinct disorder, belongs to the genetically heterogeneous
cerebrofaciothoracic (CFT) dysplasia spectrum (Alanay et al.,
2014).
The TMCO1 is a highly conserved protein among species
(from slime-mold to human), implicating an evolutionarily
conserved physiological function for TMCO1. However, the
physiological function of TMCO1 is not known, nor the patho-
genic mechanism of CFT dysplasia spectrum. Here, we
provide biochemical and imaging, molecular and cellular,
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Figure 1. TMCO1 Is a Transmembrane-
Spanning ER-Located Protein, with Both N
and C Termini Stretched into the Cytoplasm
(A) HeLa cells expressing myc-tagged TMCO1
and endoplasmic reticulum (ER)-targeted DsRed
(ER-DsRed) were fixed, permeabilized, and
immunostained with anti-myc antibodies.
(B) Surface-labeling of Myc-Flag tagged TMCO1.
Myc- and Flag-tag were located on the opposite
side of the first transmembrane domain in TMCO1
(as shown in H). Immunostaining of Myc and Flag
were carried out in intact (upper row, no Triton X)
and permeabilized (lower row, with Triton X-100)
cells. GFP-Orai1 was chosen as a marker of
plasma membrane.
(C) Subcellular fractionation of HeLa cells. The
post-nuclear supernatant (PNS) was fractionated
on 30% Percoll and then subjected to western
blotting with different antibodies. Calnexin and
P62, ER proteins; Tim23, mitochondrial protein;
GM130, Golgi protein.
(D) The TMCO1 presents in membrane fraction.
Cytosol and total membrane from HeLa PNS were
immunoblotted for TMCO1.
(E) TMCO1 is resistant to alkaline extraction. Both
the pellet and the soluble fractions after alkaline
extraction were immunoblotted for TMCO1 and
Bip (ER intraluminal protein).
(F) Membrane topology experiments of TMCO1.
PNS from HeLa cells expressing TMCO1 with
either N-myc or C-myc tags were digested with
proteinase K in the presence or absence of Triton
X-100 followed by western blot analysis.
(G) Fluorescence recovery after photo-bleaching
(FRAP) experiments of TMCO1-GFP. Rtn-4a and
Sec61-beta are ER transmembrane proteins with
low and high diffusible rates, respectively.
(H) Schematic representation of the membrane
topology of TMCO1. Both N and C termini of
TMCO1 were located in the cytoplasm.
See also Figure S1.electrophysiological, and in vivo mouse model data demon-
strating that TMCO1 is an ER transmembrane protein, which re-
sponses to ER luminal Ca2+ overloading by homotetramerization
and functions as a Ca2+ overload-assembled Ca2+ release chan-
nel. This Ca2+ load-activated Ca2+ (CLAC) release channel con-
stitutes a conserved general mechanism for cells to prevent ER
Ca2+ store from overfilling and thus maintains a homeostasis in
ER Ca2+ store. TMCO1-defect syndrome mutations fail to
assemble the homotetramers leading to the CLAC channeldisruption, which could be the underlying
pathogenic mechanisms for human CFT
dysplasia spectrum.
RESULTS
TMCO1 Is an ER Transmembrane-
Spanning Protein
TMHMM sequence analysis of TMCO1
predicted two transmembrane segments(amino acids 9–31 for TM1 and amino acids 91–109 for TM2) and
a hydrophobic stretch (amino acids 143-154) (Figures S1A and
S1B). To examine the subcellular localization of TMCO1, myc-
tagged TMCO1 was expressed in HeLa cells. Immunostaining
of myc-TMCO1 showed perfect colocalization of myc-TMCO1
with ER tracker (Figure 1A), and the first transmembrane
segment (TM1) of TMCO1 is essential for its ER localization
(Figures S1C and S1D). Surface-labeling of two-side-tagged
TMCO1 demonstrated that TMCO1 is not a plasma membrane                                
protein (Figure 1B). We next generated a polyclonal antibody
against TMCO1 that is able to recognize the endogenous
TMCO1 protein in immunoblotting analysis. Percoll gradient
fractionation of the post-nuclear supernatant (PNS) revealed
that endogenous TMCO1 is associated with the ERmarkers (cal-
nexin, P62) but not the mitochondrial (Tim 23) or Golgi (GM130)
marker (Figure 1C). TMCO1 was presented in the membrane
fraction (Figure 1D) and was resistant to alkaline extraction (Fig-
ure 1E), demonstrating that TMCO1 is an ER transmembrane-
spanning protein rather than a membrane-associated protein.
To determine the membrane topology of TMCO1, the PNS
from HeLa cells expressing TMCO1 with either an N-myc or
C-myc tag was digested with proteinase K in the presence or
absence of Triton X-100 followed by western blot analysis. Bip,
an ER luminal protein, was resistant to protease digestion unless
the PNS was permeabilized by detergent, suggesting that the
PNS membranes were intact (Figure 1F). In the same digestion
conditions, both N-myc and C-myc tags were sensitive to prote-
ase digestion even in the absence of detergent, indicating that
both N terminus and C terminus of TMCO1 are located in the
cytoplasm (Figures 1F and 1H). Rtn-4a and Sec61-beta are
known ER transmembrane proteins with low and high diffusion
rates, respectively. Fluorescence recovery after photo-bleach-
ing (FRAP) experiments revealed that the mobility of TMCO1 in
the ER membrane was much higher than that of Rtn-4a and
lower than that of Sec61-beta (Figure 1G), indicating that
TMCO1 protein diffuses readily throughout the ER membrane.
Loss of TMCO1 Causes Supernormal Ca2+ Signaling
and Overload of ER Ca2+ Store
ER is the main intracellular Ca2+ store and plays a central role in
intracellular Ca2+ mobilization and dynamics (Berridge et al.,
2003). To examine the potential role of TMCO1 in Ca2+ signaling
system, we established TMCO1 knockdown (KD) cell lines.
Knocking down TMCO1 did not change the morphology of the
cell (Figures S2A and S2B) or the expression levels of InsP3Rs
and Ca2+ pumps (sacro/ER Ca2+ ATPase [SERCA]) (Figure S2C).
ATP, an agonist of PLC-InsP3-coupled receptor, elicited several
Ca2+ spikes in wild-type (WT) cells (Figure 2A), while KD cells ex-
hibited a supernormal Ca2+ signaling in response to the same
concentration of ATP: long-lasting Ca2+ spikes or a plateau-
like Ca2+ transient (Figure 2B). Intracellular Ca2+ store is impor-
tant for this supernormal Ca2+ signaling, as the supernormal
Ca2+ signaling was still observed even in Ca2+-free medium (Fig-
ures 2C, 2D, and S3A–S3C). Uncaged InsP3 induced significantly
higher amplitude of Ca2+ transient in KD cells as compared to
WT cells (Figures 2E and 2F). Thapsigargin (TG), an inhibitor of
SERCA Ca2+ pumps, induced more massive and longer-lasting
Ca2+ signals in KD cells than in WT cells (Figures 2G and S3D–
S3F). The size of TG-sensitive Ca2+ pools (the integrated areas
under the TG-induced cytosolic Ca2+ curves) is 2.1-fold larger
in KD cells than that in WT cells (Figure 2H). The supernormal
Ca2+ signal and the increased size of TG-sensitive Ca2+ pools
in KD cells were completely rescued by the expression of full-
length TMCO1, but not by the Ser47X truncation (amino acids
1–46), the mutation in TMCO1-defect syndrome (Figures 2G,
2H, and S3A–S3F), indicating that loss of TMCO1 function leads
to overfilled ER Ca2+ store in KD cells. The filling state of ER Ca2+                                store was further confirmed by the ER-targeted cameleon
(D1ER), a fluorescence resonance energy transfer (FRET)-based
ER Ca2+ indicator (Palmer et al., 2004). KD cells showed a signif-
icantly higher ER Ca2+ concentration than WT cells (Figures 2I
and 2J). Furthermore, expression of TMCO1but not 1–46 trunca-
tion reduced the high level of ER Ca2+ in KD cells to the normal
level (Figures 2I and 2J), confirming that loss of TMCO1 leads
to overfilling of ER Ca2+ store. Interestingly, ectopic expression
of TMCO1 in WT cells almost depleted ER Ca2+ stores (Figures
S3G and S3H), and TMCO1 protein levels inversely correlated
with the size of ER Ca2+ stores (Figures S3G and S3I), supporting
an important role of TMCO1 in regulating the Ca2+ content in ER
store. Notably, expression of Caenorhabditis elegans or zebra-
fish TMCO1 also reduced the high level of ER Ca2+ in KD cells
to normal level, suggesting that the function of TMCO1 is evolu-
tionarily conserved (Figures S3J and S3K). While TMCO1 knock-
ing-down did not change the basal cytosolic Ca2+ levels in
resting cells (Figures 2K and 2L), overexpression of TMCO1 in
WT cells exhibited a dose-dependent elevation of basal cyto-
solic Ca2+ levels in both Ca2+-containing (Figure 2M) and Ca2+-
free medium (Figure 2N), indicating that TMCO1 overexpression
causes increased Ca2+ release from internal store.
Tetramerization of TMCO1 in Response to the Overload
of ER Ca2+ Store
Overload of ER Ca2+ store caused by loss of TMCO1 prompted
us to determine if TMCO1 acts as a Ca2+ channel across the ER
membrane to prevent the Ca2+ store from overfilling. If this is the
case, the functional TMCO1 channel must form an oligomeric
complex comprising several TMCO1 subunits. To determine
the TMCO1 stoichiometry, we applied similar biochemical
techniques used previously to solve the stoichiometry of other
channels. Co-immunoprecipitation results revealed that the
full-length TMCO1, but not the 1–46 truncation, can co-
assemble with full-length TMCO1 (Figure 3A). Treatment of
HeLa cell lysates with increasing concentrations of two different
lysine-reactive crosslinkers produced cross-linked species with
sizes of40,80, and160 kDa on SDS-PAGE, consistent with
the molecular masses of TMCO1 dimers, tetramers, and oc-
tamers, respectively (Figures 3B and 3C). The molecular mass
of TMCO1 monomer is predicted 21 kDa, and the size of
cross-linked oligomeric species observed are integer multiples
of the 21 kDa TMCO1 monomer, indicating that the cross-
linked products are integral homomultimers of the monomeric
TMCO1 (Figures 3B and 3C).
Overload of ER Ca2+ stores may influence the TMCO1 stoichi-
ometry. To analyze the effects of theCa2+ filling state in the ER on
TMCO1 stoichiometry, we performed chemical cross-linking
experiments with HeLa cell lysates from the resting, Ca2+
store-depleted (TG + EGTA), and Ca2+ store-overloaded (8%
ethanol) cells (Figure 3D). ER Ca2+ store depletion caused a
slight decrease in the cross-linked tetramer intensity of TMCO1
(Figure 3D), while the ER Ca2+ store overload resulted in a 2.5-
fold increase in the intensity of TMCO1 tetramers (Figure 3D),
suggesting that the Ca2+ store overload induces tetramerization
of TMCO1. To visualize the TMCO1 oligomerization in situ and in
real-time, we expressed CFP- and YFP-tagged TMCO1 simulta-
neously in cells and analyzed the assembly of TMCO1 by FRET
A B
C D
E F
G H
I J
K M
L N
Figure 2. Loss of TMCO1 Leads to Super-
normal Ca2+ Signaling and ER Ca2+Overload
(A and B) ATP (1 mM)-evoked Ca2+ signaling in wild-
type (WT) (A) and TMCO1 knockdown (KD) (B) cells
in Ca2+-containing medium. Fura-2 (340/380 ratio)
was used to indicate the cytosolic Ca2+ concen-
tration.
(C and D) ATP (1 mM)-evoked Ca2+ signaling in WT
(C) and KD (D) cells in Ca2+-free medium.
(E and F) Uncaged InsP3 (2 mM)-triggered Ca
2+
transients in WT cells (blue trace line, n = 17) and
KD cells (red trace line, n = 17) in Ca2+-free me-
dium. Cytosolic Ca2+ concentration was repre-
sented byDF/F0 of Fluo-4. (F) Histogram shows the
average amplitudes of InsP3-triggered Ca
2+ tran-
sients (mean ± SEM).
(G and H) Thapsigargin (TG)-triggered Ca2+ tran-
sients in WT (blue trace line, n = 23), KD (red trace
line, n = 23), KD cells expressing TMCO1 (green
trace line, n = 21), and KD cells expressing TMCO1
Ser47X truncation mutant (1–46, purple trace line,
n = 22). (H) Histogram shows the average peak area
of TG-triggered Ca2+ transients (mean ± SEM) in
each group.
(I and J) ER Ca2+ levels were monitored by ER-
targeted cameleon (D1ER) in WT (blue trace line,
n = 80), KD (red trace line, n = 65), KD cells ex-
pressing TMCO1 (green trace line, n = 70), and KD
cells expressing TMCO1 Ser47X truncation mutant
(1–46, purple trace line, n = 55). The ER Ca2+ con-
centration was represented by mM. (J) Histogram
shows the average ER Ca2+ levels in resting cells
(mean ± SEM) in each group. Each trace line in (E),
(G), and (I) is an average of Ca2+ responses from all
cells in each group. All the experiments were
repeated at least three times with similar results.
(K) Cytosolic Ca2+ levels in WT (n = 48) and KD (n =
49) HeLa cells.
(L) Cytosolic Ca2+ levels inWT (n = 23), HET (n = 27),
and KO (n = 24) MEFs.
(M) Basal cytosolic Ca2+ levels in HeLa cells ex-
pressing TMCO1-YFP or YFP. Expression groups
that cover the whole YFP fluorescence signals
were created by grouping 20–50 cells (TMCO1-
YFP, n = 150; control-YFP, n = 90). The average
basal Ca2+ levels are plotted as a function of
expression groups.
(N) Cells from (M) were changed to Ca2+-free me-
dium, and the average basal cytosolic Ca2+ levels
were plotted to fluorescence ranges using the
same data collected in (M). *p < 0.05, **p < 0.01,
***p < 0.001; ns, no significance.
See also Figures S2 and S3.
                                
Figure 3. TMCO1 Undergoes Oligomeriza-
tion and Forms Tetramers in Response to
ER Ca2+ Overload
(A) Co-immunoprecipitation experiment (coIP)
shows TMCO1 forms a complex with itself. The
input lanes contained 1/30 of lysates used in coIP
reactions. Representative of at least three inde-
pendent experiments.
(B and C) Determination of the TMCO1 stoichi-
ometry via chemical cross-linking. Increasing
concentrations of glutaraldehyde (GA) (B) and
disuccinimidyl suberate (DSS) (C) were used as
indicated. Numbers represents the state of oligo-
merization: 1, monomer; 2, dimer; 4, tetramer; 8,
octamer. Representative of at least three inde-
pendent experiments.
(D) Similar experiments as (C) were performed on
HeLa cell lysates prepared from resting cells, cells
pre-treated with TG in Ca2+-free medium
(TG+EGTA), and cells pre-treated with 8% ethanol
in Ca2+-containing medium (8% ethanol). Repre-
sentative of at least three independent experi-
ments.
(E) D1ER indicated ER Ca2+ concentration
manipulated by 8% ethanol in Ca2+ containing
medium and by TG in Ca2+-free medium (mean ±
SEM, n = 9). Each trace line is shown in mean ±
SEM.
(F) Time course of mean FRET ratio changes
measured from individual cells expressing CFP-
and YFP-tagged TMCO1 (green trace line, n = 16)
or 1–46 (purple trace line, n = 6) after application of
ethanol and TG. The FRET/CFP ratio before
treatment was considered as basal, and FRET
changes were represented in percentiles: 100 3
(R-Rbasal)/Rbasal. FRET increase means the as-
sembly of TMCO1 and vice versa. Each trace line
is shown in mean ± SEM.
(G and H) ER Ca2+ changes manipulated by 8%
ethanol and TG in Ca2+ free medium (n = 21). FRET
signal change of TMCO1 were shown in (H) (n =
25). Each trace line is shown in mean ± SEM.
(I) ER Ca2+ changes manipulated by 8% ethanol
and TG in 40 mM of BAPTA-AM loaded cells (red
trace line, n = 12). DMSO were used as control
(blue trace line, n = 10). Each trace line is shown in
mean ± SEM.
(J) FRET changes of TMCO1 were monitored
according to the same procedure as above.
Curve for control (DMSO, blue trace line, n = 9) and
pre-treatment with BAPTA-AM (red trace line,
n = 12) were shown. Each trace line is shown in
mean ± SEM.
See also Figure S4.method. TMCO1-CFP/YFP fusion proteins are functional if CFP
or YFP is fused with the C terminus of TMCO1 (Figures S4C–
S4F). Ethanol treatment induced an increase of ER Ca2+ concen-
tration from a resting of 500 mM to an overloaded state of
650 mM. In contrast, TG depleted the ER Ca2+ effectively (Fig-
ure 3E). Accordingly, the FRET signal was increased20%upon
ethanol-induced ER Ca2+ overload and reduced to 5% when
ERCa2+was depleted (Figure 3F), indicating that the TMCO1 un-
dergoes oligomerization in response to ER Ca2+ overload, and
oligomerized TMCO1 (likely tetramers) rapidly disassembles                                when ER Ca2+ store returns to resting levels. 1–46 TMCO1 trun-
cations lost the capability of oligomerization in response to 8%
ethanol treatments (Figure 3F). Further data demonstrated that
the effects of 8% ethanol on the changes of D1ER and FRET
were [Ca2+]ER-dependent (Figures 3G–3J).
This reversible assembly/disassembly of TMCO1 at the single-
molecule level in the native membrane environment was further
determined by a photo-bleaching-step assay of TMCO1-GFP
in TIRFM image. Continuous laser bleaching resulted in a step-
wise decrement of GFP fluorescence at the diffraction-limited
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Figure 4. Tetramerization of TMCO1-GFP at
the Single-Molecule Level in Response to
the Overload of ER Ca2+ Store in Living Cells
(A) Representative TIRF images (first row) acquired
before photo bleaching showed fluorescent spots
(circled in green) sparsely distributed in the endo-
plasmic reticulum membrane of a HeLa cell ex-
pressing TMCO1-EGFP. Magnified views of boxed
regions were also shown (second row). Laser
photobleaching of GFP fluorescence is performed
in TMCO1-GFP expressing HeLa cells (resting
group, n = 5 cells, 226 spots; TG + EGTA group, n =
4 cells, 176 spots; 8% ethanol group, n = 4 cells,
306 spots).
(B–D) Representative examples of single-molecule
laser bleaching traces recorded from HeLa cells.
Two and four steps of laser bleaching traces were
shown in (B), (C), and (D).
(E) Distribution of GFP-fluorescence bleaching
stepswith TIRF laser in living HeLa cells expressing
TMCO1-EGFP. One to four steps of laser bleaching
was shown in columns with dots, white, grid and
black. Data are represented as mean ± SEM,
***p < 0.001.fluorescent spots in TMCO1-GFP-expressing HeLa cells (Fig-
ures 4A–4D). The numbers of bleaching steps, ranging from
one to a maximum of four, corresponding to the numbers of
GFP molecules bleached at these spots (Figures 4B–4D). In
resting HeLa cells, most of the spots (65%) exhibited two steps
to complete bleaching, and a small fraction (20%) of these
spots showed four bleaching steps (Figures 4C and 4E). ER
Ca2+ overload resulted in a decrease of two-step bleaching
spots (28%) and an increase of four-step bleaching spots
(64%) (Figures 4D and 4E), whereas depletion of ER Ca2+ re-sulted in a completely opposite effect
(Figures 4B and 4E). Therefore, TMCO1
is present in the ER membrane predomi-
nantly as dimers under resting conditions,
and ER Ca2+ overload induces dimeriza-
tion of TMCO1 dimers to form tetramers
(Figure 4E), which could be functional as
a putative Ca2+ channel across the ER
membrane.
TMCO1 Forms a Ca2+ Permeable
Channel across the ER Membrane
To determine whether TMCO1 is capable
of forming a Ca2+-permeable channel, we
purified the TMCO1 proteins (Figure S5)
and reconstituted them into liposomes.
We successfully recorded the single
channel currents with a conductance of
66 pS from liposomes incorporated with
the wild-type TMCO1 protein (Figure 5A).
In contrast, the disease mutant protein
(Ser47X truncation) did not show any
detectable channel currents (Figure 5B).
The monovalent cation:anion selectivitywas determined from reversal potentials measured in the pres-
ence of a 10-fold KCl gradient. TMCO1 exhibited an average
reverse potential of 49.4 ± 2.1 mV, which gave rise to an esti-
mated PK/PCl of 24.6, indicating that TMCO1 is a cation selective
channel (Figure 5D). The Ca2+ preference was then measured
by the shift of reversal potential (DErev) when CaCl2 was added
to the bath solution (Figure 5D). Addition of 10 mM Ca2+ into
bath solution caused the reversal potential of TMCO1 shifted
from 49.4 ± 2.1 mV to 5.1 ± 0.2 mV (Figures 5A, 5D, and 5K;
Table 1). This substantial shift of reversal potential suggested                                
Figure 5. TMCO1 Protein Forms Ca2+-Selec-
tive Ion Channels
(A) Single channel currents of TMCO1 were re-
corded from reconstituted giant liposome by the
inside-out patch-clamping method. The traces re-
corded at 80 mV and 80 mV membrane voltages
without or with 10 mM CaCl2 in bath solutions were
shown.
(B) TMCO1 disease mutant Ser47X truncation did
not show any measurable currents.
(C) Histogram analysis of TMCO1 single channel
current recorded at 80 mV as shown the top trace in
(A), and two terms Gaussian fitting gave a high open
probability (Po) of 0.68.
(D) The I-V plot by single channel conductance (pA)
versusmembrane voltage (mV). The black circle (C)
represents the control solution (10:1 KCl gradient)
without CaCl2, and reversal potential of I-V is 49.4
± 2.1 (mV), n = 5 patches. The black triangles (:)
represent the currents recorded after adding 5 mM
CaCl2 into the bath solution, with a reversal poten-
tial of15.3 ± 0.5, n = 4 patches. The black squares
(-) indicate the currents recorded after introducing
10 mM CaCl2 into the bath solution, and the aver-
aged reversal potential is 5.1 ± 0.2 mV, n = 4
patches.
(E) Thapsigargin (TG)-inducedCa2+ transients inWT
(blue trace line, n = 29), KD (red trace line, n = 27),
KD cells expressing TMCO1 mutant D140A (purple
trace line, n = 31), and KD cells expressing TMCO1
mutant D140E (green trace line, n = 35).
(F) Histogram shows the average peak area of
TG-triggered Ca2+ transients (mean ± SEM) in each
group.
(G) Single channel current traces of TMCO1 mutant
D140E recorded at 80 mV and 80 mV membrane
voltages without or with 10 mM CaCl2 in bath so-
lution were shown.
(H) I-V curves of TMCO1 mutant D140E. Reversal
potential shifted to right after addition of 5 mM or
10 mM CaCl2 in bath solution.
(I) Single channel current traces of TMCO1 mutant
D140A.
(J) I-V curves of TMCO1 mutant D140A. Note that
there is no reversal potential shift after addition of
5 mM and 10 mM CaCl2 in bath solution.
(K) Summarized shift of reversal potential of WT
TMCO1, D140E mutant, and D140A mutant after
adding 5 mM or 10 mM CaCl2 in bath solution.
See also Figures S5 and S6.that TMCO1 was obviously selective for Ca2+. The conductance
of TMCO1 reduced to 53.6 pS after adding 10 mM CaCl2 in the
bath solution (Table 1), which displayed a little inhibition of
conductance, a typical phenomenon of Ca2+ permeation
observed on the cyclic nucleotide-gated (CNG) ion channel
(Almers and McCleskey, 1984; Frings et al., 1995). Many Ca2+
channels, such as CNG channels and IP3 receptors (IP3Rs),
also conduct monovalent cations in the absence of divalent
cations (Bezprozvanny and Ehrlich, 1994; Finn et al., 1997;
Foskett et al., 2007).                                To see if such conductance is present in vivo, we performed
ER membrane patch clamp experiments. We made a tandem
4 3 TMCO1 expressing plasmid and found that expression of
tandem 4 3 TMCO1 completely depleted the ER Ca2+ content,
indicating that tandem 4 3 TMCO1 is functional on ER (Figures
S6A and S6B). ER patch-clamp recording of tandem 4 3
TMCO1 expressing CHO cells mainly include two types of single
channel: 12 out of 19 patches record small currents with 50.3 pS
conductance (Figures S6C and S6E) and occasionally the large
current 400 pS, which is probably the currents of IP3R or
Table 1. Characterizations of TMCO1 Channel and D140E, D140A Mutants
Erev (mV) Conductance (pS)
WT D140E D140A WT D140E D140A
0 mM CaCl2 49.4 ± 2.1 32.8 ± 0.6 48.9 ± 1.3 66 ± 5.6 63.2 ± 9.6 81.7 ± 4.1
5 mM CaCl2 15.3 ± 0.5 21.2 ± 1.2 45.3 ± 0.4 56 ± 5.9 67.0 ± 17.3 67.1 ± 4.0
10 mM CaCl2 5.1 ± 0.2 3.9 ± 0.6 47.5 ± 2.2 53.6 ± 6.3 62.0 ± 9.8 58.7 ± 5.5
The values of reversal potential (Erev, mV) and conductance of WT TMCO1, D140E, and D140A under asymmetric KCl solution (bath, 15 mM KCl;
pipette, 150 mM KCl) with 0 mM, 5 mM, or 10 mM CaCl2 in the bath solution were analyzed. The data are represented as the mean ± SEM,
n = 4–7 patches.RyR. The dominant currents of tandem 4 3 TMCO1 has single
channel conductance and open probability (Figure S6D, Po =
0.66) similar to the current of TMCO1 recorded from reconsti-
tuted giant liposome. In contrast, we were not able to record
such single channel conductance in control CHO cells. There-
fore, we have recorded the in vivo TMCO1 channel activity on
ER membrane by ectopic expression of tandem 4 3 TMCO1,
supporting that TMCO1 is able to form a single channel conduc-
tance on ER membrane.
To further confirm that TMCO1 is a Ca2+ selective channel, we
searched for the amino acids that potentially line the pore and
interact with Ca2+. We focused on the negatively charged resi-
due aspartate at position 140 (D140) before the third hydropho-
bic stretch and changed it to either an alanine (D140A) or a
glutamate (D140E) by site-directed mutagenesis. By functional
evaluation of these mutations in Ca2+ imaging experiments, we
found that charge-neutralizing mutant (D140A) lost the Ca2+
permeation function, whereas the charge-preserved mutant,
D140E, still retained the ability to expel Ca2+ out of ER (Figures
5E and 5F).
These two mutants were then expressed, purified accordingly
(Figure S5), and reconstituted into giant liposomes followed by
patch-clamp experiments. Our electrophysiological results re-
vealed that D140E mutation significantly reduced the shift of
reversal potential (Erev from 32.8 ± 0.6 mV to 3.9 ± 0.6 mV
in the presence of 10 mM CaCl2, Figures 5G, 5H, and 5K; Table
1), indicating that D140E attenuates the Ca2+ selectivity of
TMCO1 channel. On the contrary, while D140Amutation showed
a comparable K+ preference (Erev = 48.9 ± 1.3 mV; PK/PCl
22.4) as wild-type TMCO1, the reversal potential of D140A un-
derwent almost no change after adding 10mMCa2+ into the bath
solution (Figures 5I–5K; Table 1), revealing that substitution of
D140 to an alanine eliminated the Ca2+ permeability of TMCO1
channel. Our results with point mutations therefore demonstrate
that aspartate at position 140 is a key residue in the determina-
tion of Ca2+ preference and Ca2+ permeability of TMCO1,
supporting the conclusion that TMCO1 can function as a Ca2+
channel across the ER membrane.
TMCO1 Knockout Mice Show a Delayed Osteogenesis,
Mental Retardation, Ataxia, and Severe ER Ca2+
Mishandling
To examine the physiological role of TMCO1 in vivo, we gener-
ated TMCO1 knockout (KO)mice (Figure S7A).Mutantmice lack-
ingTMCO1were viable.However, thebirth rate ofKOpups is only
8.9%,which ismuch less than theoretical probability of 25% fromheterozygousmatings, suggestinganantepartumdeathofKO fe-
tuses (Figure 6A). TMCO1-KO pups exhibited a reduced body
size (Figure S7B), low survival rate (Figure 6B), and delayed os-
teogenesis (Figures 6C and 6D). Micro-CT images of adult
TMCO1-KO mice revealed the craniofacial dysmorphism such
as open cranial sutures (Figure 6E; Movies S1 and S2), flattened
faces with shorten nasal bones (Figure S7C), and skull anomalies
(Figure S7D). Furthermore, magnetic resonance imaging (MRI) of
TMCO1-KO mouse brain showed significantly enlarged brain
ventricles (Figure 6F), suggesting a mental retardation in
TMCO1-KOmice. Consistently, adult TMCO1-KOmice manifest
the significant deficiency in spatial recognition memory in a
Y-maze task assay (Figure 6G). The TMCO1-KO mice also
showed a significant deficiency in motor coordination in rotarod
assessments (Figure 6H). Thus, our TMCO1-KO mice recapitu-
late the main clinical features of human TMCO1 defect patients
includinghigh rateofmiscarriage, developmental delay, craniofa-
cial dysmorphism, enlarged brain ventricles, mental retardation,
and unstable gait (Alanay et al., 2014; Xin et al., 2010), demon-
strating that disruption of TMCO1 function in mice can cause
similar symptoms to that of human CFT dysplasia spectrum.
Notably, Ca2+ imaging results revealed the significant overload
of ER Ca2+ in TMCO1-KO osteoblasts (Figures 6I, 6J, S7E, and
S7F), illustrating the severemishandling of ER Ca2+ after ablation
of TMCO1 in osteoblasts, which could be the underlying mecha-
nism for the craniofacial anomalies in CFT dysplasia spectrum.
Taken together, we propose a model of how the ER Ca2+ store
homeostasis is actively maintained by TMCO1. Our results show
that TMCO1, a gene mutated in ‘‘TMCO1 defect syndrome/CFT
dysplasia spectrum,’’ encodes an evolutionarily conserved ER
transmembrane-spanning protein. Overfilling of the ER with Ca2+
induces homotetramerization of TMCO1 to form an ER Ca2+
release channel. Ca2+ release via TMCO1 channels resets the ER
Ca2+concentration to resting level. TMCO1homotetramers rapidly
disassemble to terminate the channel activity when ER Ca2+ re-
turns to resting level, thereby maintain a steady-state of ER Ca2+
levels in cells. Disease mutant TMCO1 proteins (such as the dis-
ease mutation Ser47X) failed to assemble a Ca2+ release channel
and thus lose the function of preventing ER Ca2+ store from over-
load, leading to severe mishandling of ER Ca2+ and pathologies
of human CFT dysplasia spectrum.
DISCUSSION
ER intraluminal Ca2+ concentration is crucial for initiation of
proper Ca2+ signaling (Berridge et al., 2003; Clapham, 2007),                                
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as well as correct protein folding and maturation (Austin, 2009;
Xu et al., 2005). The content of ER Ca2+ store should be
constantly monitored to maintain an ER Ca2+ homeostasis.
STIM, an ER single-pass transmembrane protein, detects ER
Ca2+ depletion (Liou et al., 2005; Roos et al., 2005; Stathopulos
et al., 2008; Zhang et al., 2005), undergoes oligomerization (Baba
et al., 2006; Liou et al., 2007; Wu et al., 2006), and directly binds
to Orai (Muik et al., 2008; Park et al., 2009), causing the opening
of the CRAC channel and initiation of Ca2+ entry to convey Ca2+
signals and to refill ER Ca2+ stores (Feske et al., 2006; Luik et al.,
2008; Park et al., 2009; Prakriya et al., 2006; Roos et al., 2005;
Vig et al., 2006; Yeromin et al., 2006; Yuan et al., 2009; Zhang
et al., 2005). Here, we identify TMCO1 as an ER Ca2+ channel
that detects ER Ca2+ overfilling and actively regulates ER Ca2+
content. TMCO1 is capable of sensing the ER Ca2+ overload sta-
tus, assembling into a Ca2+ channel by homotetramerization,
and thus releasing Ca2+ from ER store. Intriguingly, TMCO1 tet-
ramers rapidly disassemble to terminate the Ca2+ channel activ-
ity when ER Ca2+ returns to resting levels. We believe that this
reversible tetramerization/disassembly of TMCO1 in response
to different ER Ca2+ levels constitutes an important and general
mechanism for the maintenance of ER Ca2+ homeostasis. We
name this channel as Ca2+ load-activated Ca2+ (CLAC) channel.
In resting cells, the steady-state ER Ca2+ level is determined
by an equilibrium between SERCA-mediated Ca2+ uptake from
the cytosol into the ER lumen and the passive leak of Ca2+
from ER into the cytosol (Berridge et al., 2003; Clapham,
2007). A number of candidates have been previously shown to
play a role as Ca2+ passive leak channels, such as presenilins
(Tu et al., 2006), BCL-2/IP3R (Oakes et al., 2005), Bax inhibitor-
1(Bultynck et al., 2012; Chae et al., 2004), and ryanodine recep-
tor in cardiac cells (Jiang et al., 2005). Unlike the ‘‘passive’’ ER
Ca2+ leak channels, TMCO1 is an ‘‘active’’ Ca2+ release channel
that is assembled via homotetramerization in response to over-
filled Ca2+ in the ER (Figures 3 and 4). The majority of TMCO1
do not assemble as homotetramers until the ER Ca2+ content
reaches a critical high level, indicating that the main function ofFigure 6. TMCO1 Knockout Mice Show a Delayed Osteogenesis, Ment
(A) Percentage of each genotype at birth. WT, wild-type; HET, heterozygote; KO
erozygous matings.
(B) Survival rate of each genotype. Data are calculated from an overall 112 pups
(C) Alizarin Red S and Alcian Blue staining of the skulls of P4mice. KOmouse skull
than its WT littermates.
(D) Histological analysis of P1 WT and KO mouse skulls. HE stainings show
sagittal suture of KO pups (lower panels, pointed out with arrows) when comp
discontinuous osteoid deposition is seen at KO osteogenic fronts (lower enlarge
mice. Enlarged section was indicated with gray box in first and third panels. B, br
and fourth panels).
(E) Micro-CT of the skulls of 5-month-old WT and KO mice. KO skull shows obvio
sutures. Representative data from at least three KO mice are shown.
(F) Magnetic resonance imaging (MRI) of brains of 5-month-old mice show enlar
(G) Y-maze task assay of adult WT and KOmice. Relative distance walked (left pan
arm over start arm decrease significantly (*p < 0.05) than WT mice (white column
(H) Rotarod performance of adult WT and KOmice. An average latency to fall from
n = 8) and the KO mice (red, n = 6) in 3 consecutive days. For each group of mic
(I and J) Overload of ER Ca2+ in primary osteoblasts cultured from TMCO1-KOmi
KD (red trace line, n = 28), and HET (green line, n = 23) primary osteoblasts. (J) His
SEM) in each group. Each curve in (I) is an average of Ca2+ responses from all c
See also Figure S7 and Movies S1 and S2.TMCO1 channel is to prevent ER store from overload of Ca2+.
Because 20% of TMCO1 exist as homotetramers in resting
cells (Figures 3F, 4C, and 4E), we consider that TMCO1 channel
also accounts for a small proportion of basal ER Ca2+ leaking ac-
tivity. This is further supported by the fact that knocking-down of
TMCO1 leads to overload of ER Ca2+ store (Figures S3D–S3F),
and overexpression of TMCO1 in WT cells almost depletes the
ER Ca2+ store (Figures S3G–S3I).
Ca2+ influx system can also affect ER Ca2+ homeostasis.
Capacitive Ca2+ entry through SOCEmachinery is one of thema-
jor pathways for Ca2+ influx. SARAF, an ER located protein, has
recently been discovered acting as an inhibitor of SOCEmachin-
ery to prevent excess Ca2+ refilling (Palty et al., 2012). Knocking-
down SARAF can increase SOCE activity and thus causes ER
Ca2+ overloading. We consider that SARAF and TMCO1, which
act on plasma membrane SOCE machinery and ER membrane,
respectively, work together to prevent ER Ca2+ overfilling and
thus protect cells.
The TMCO1 gene has highly conserved amino acid sequence
among species, and complementation of the human TMCO1
gene function can be achieved by expressing either C. elegans
or zebrafish TMCO1 protein (Figures S3J and S3K), indicating
that the TMCO1-mediated CLAC activity is an evolutionarily
conserved mechanism for the homeostatic maintenance of ER
Ca2+. Given that homeostatic maintenance of ER Ca2+ is critical
for proper Ca2+ signaling and cell functions (Berridge et al.,
2003; Clapham, 2007), TMCO1 disease mutations-caused over-
loadofERCa2+ storeandsupernormal intracellularCa2+ signaling
could be the underlying pathogenic mechanisms for human CFT
dysplasia spectrum. Indeed, this has been confirmed by our
TMCO1-knockout mouse model, which manifests severe mis-
handling of ERCa2+ in disease-affected cells such as osteoblasts
from newborn KO mouse skulls and a delayed osteogenesis.
Our TMCO1-KO mice successfully modeled the main clinical
features of human TMCO1-defect syndrome such as develop-
mental delay, craniofacial dysmorphism, enlarged brain ventri-
cles and mental retardation, and unstable gait. We haveal Retardation, Ataxia, and Severe ER Ca2+ Mishandling
, TMCO1-knockout. Data are calculated from an overall 112 pups from het-
from heterozygous matings.
s exhibit a significantly wider open frontier suture (between the two arrowheads)
a significant wider gap between the left and right osteogenic fronts at the
ared with their WT littermates (upper panels, pointed out with arrows), and
d panel, pointed out with arrows), revealing a delayed osteogenesis in P1 KO
ain; P, parietal bone. Scale bars, 250 mm (first and third panels); 25 mm (second
us gaps along the midline interfrontal suture, transverse coronal and lambdoid
ged ventricles in KO mouse.
el) and relative time spent (right panel) of KOmice (black column, n = 6) in novel
, n = 10).
the accelerating rotarod is shown for WTmice (blue, n = 10), HET mice (green,
e, the results are shown as mean ± SEM. *p < 0.05; **p < 0.01.
ce. Curves represent TG-induced Ca2+ transients in WT (blue trace line, n = 34),
togram shows the average peak area of TG-triggered Ca2+ transients (mean ±
ells in each group. ***p < 0.001.
                                
previously described an autosomal-recessive syndrome, i.e.,
TMCO1-defect syndrome in the isolated Old Order Amish of
northeastern Ohio (Xin et al., 2010). Recently, more Turkish ori-
gins of TMCO1-defect syndrome have been reported (Alanay
et al., 2014; Caglayan et al., 2013). A combination of homozygos-
ity mapping and whole-exome sequencing analysis of these pa-
tients of different origins have identified the pathogenic
nonsense mutations in a single TMCO1 gene (c.139_140delAG
mutation, p.Ser47X truncation for Amish; c.259 C > T mutation,
p.Arg87X truncation for Turkish). TMCO1-defect syndrome
shares many features with cerebrofaciothoracic (CFT) dysplasia
and could be considered to belong to the genetically heteroge-
neous CFT dysplasia spectrum (Alanay et al., 2014). The
TMCO-deficient mousemodel we created provides an important
reagent for both molecular pathogenic mechanism studies and
therapeutic target studies on CFT dysplasia spectrum in the
future.
In summary, we have identified the TMCO1 as a conserved,
important regulator of ER Ca2+ homeostasis. TMCO1 detects
the ER Ca2+ loading status, undergoes reversible tetrameriza-
tion/disassembly, and tightly regulates the Ca2+ content in ER
store. This physiological function places TMCO1 as an important
protective mechanism designed to prevent the overfilling of ER
store with calcium ions.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
HeLa, HEK293T, and COS7 cells were propagated and maintained as Amer-
ican Type Culture Collection (ATCC) recommended. Several TMCO1 knock-
ing-down cell lines were generated by infectionwith small hairpin RNA (shRNA)
lentiviral transduction particles produced by Sigma and maintained in DMEM
containing puromycin with 10% FBS.
[Ca2+]cyto and [Ca2+]ER Measurements
Cytosolic Ca2+ concentration was measured by Fura-2 or Fluo4 as described
previously (Tang et al., 2003), and [Ca2+]ER measurements were done with
D1ER probe as described before (Palmer et al., 2004). For more details, see
the Supplemental Experimental Procedures.
Chemical Cross-linking
The following homobifunctional reagents were used for protein cross-linking:
the lysine-reactive N-hydroxysuccimide esters DSS (water-insoluble, mem-
brane permeable, spacer arm length 11.4 Å, dissolved in DMSO), and glutar-
aldehyde (GA, water-soluble, membrane permeable). Chemical cross-linking
was accomplished as described previously with some modifications (Ramjee-
singh et al., 1999). For more details, see the Supplemental Experimental
Procedures.
Single-Molecule GFP Photobleaching
The single-molecule photobleaching experiments were performed as previ-
ously described (Ulbrich and Isacoff, 2007) with some modifications.
TMCO1-GFP expressing in living HeLa cells was excited with a 488 nm laser
through a TIRF objective (1003, oil, N.A. = 1.46; Leica DMI6000). For more de-
tails, see the Supplemental Experimental Procedures.
Preparation of Giant Liposomes and Electrical Recording
The purified wild-type TMCO1 and the mutants were reconstituted into lipid
vesicles followed by dehydrate and hydrate processes. The giant liposome
recording was performed by Axon200B patch-clamp system as previously
described (Li et al., 2007). Asymmetrical solutions of 10:1 salt gradients
(pipette solution, 150 mM KCl; bath solution, 15 mM KCl) were used. Currents
were low-pass filtered at 1 or 10 kHz and sampled at 10 kHz or 100 kHz. Liquid                                junction potentials were calculated using JPCalc software (P. Barry, University
of South Wales, Sydney, Australia).
Mice
TMCO1 knockout mice were generated by Shanghai Nanfang Laboratory for
Model Organisms (Shanghai, China) using TALEN methods. TALENs targeting
Exon1 of the TMCO1 gene was constructed by the Golden gate method. For
more details and KO mouse-related assays, see the Supplemental Experi-
mental Procedures. All animal experiments were reviewed and approved by
the Institute of Zoology Institutional Animal Care and Use Committee and
were conducted according to the committee’s guidelines.
Statistical Analysis
Data are expressed as the mean ± SEM, and the statistical significance of dif-
ferences between different groups was assessed using the t test or ANOVA
with p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2016.04.051.
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